LCDX Caliber Imaging and Diagnostics Inc (CE)

Caliber Imaging & Diagnostics (OTCQB:LCDX), formerly Lucid, Inc., is exhibiting at the 64th American Association for Laboratory Animal Science National Meeting on October 27-31 in Baltimore, Maryland. The Company's exhibit will be located at Booth #2120.

At its booth, Caliber I.D. will provide live demonstrations of the VivaScope® 1500 Multilaser and the Vivascope 3000 portable handheld confocal microscope. The VivaScope 1500 Multilaser incorporates lasers at three different wavelengths within a single system, offering an unprecedented level of flexibility to researchers studying a variety of products, drugs and diseases. The VivaScope 3000 has a small probe that is designed to image lesions or other areas of interest on small or contoured body parts that are not easily imaged with Caliber I.D.'s traditional confocal devices. The VivaScope3000 can also be used as an intraoperative research device for imaging exposed living tissues within the body.

About the AALAS National Meeting

The AALAS National Meeting is the largest gathering in the world of professionals concerned with the production, care and use of laboratory animals. Held each fall since 1950, the meeting features panel discussions, seminars, presentations and workshops designed to keep attendees on the leading edge of the entire laboratory animal science field. For more information, please visit http://nationalmeeting.aalas.org/.

About Caliber Imaging & Diagnostics

Caliber Imaging & Diagnostics' platform of products offer increased productivity from the research laboratory to the doctor's office or the surgeon's operating room. Caliber I.D.'s platform of products provide precise accuracy, consistent reliability, and online backup that all combine to lead to better patient care. For more information about Caliber I.D. and its products, please visit www.caliberid.com.

VivaScope® is a registered trademark of Caliber Imaging & Diagnostics.

Safe Harbor

This press release contains "forward looking statements" within the meaning of the Securities Litigation Reform Act of 1995. These statements include but are not limited to our plans, objectives, expectations and intentions and other statements that contain words such as "expects," "contemplates," "anticipates," "plans," "intends," "believes," "assumes" and variations of such words or similar expressions that predict or indicate future events or trends, or that do not relate to historical matters. These statements are based on our current beliefs or expectations and are inherently subject to significant known and unknown uncertainties and changes in circumstances, many of which are beyond our control. There can be no assurance that our beliefs or expectations will be achieved and actual results may differ materially from our beliefs or expectations due to financial, economic, business, regulatory and other factors or conditions affecting us or our industry in general, as well as more specific risks and uncertainties facing us, such as those set forth in the Risk Factors section of the Forms 10-Q and 10-K filed by us with the Securities and Exchange Commission.

CONTACT: Richard Pulsifer
         Chief Financial Officer
         (617) 348-9821
         
         Investor Relations:
         Dian Griesel Int'l.
         Cheryl Schneider
         (212) 825-3210
         cschneider@dgicomm.com
         
         Public Relations:
         Dian Griesel Int'l.
         Susan Forman or Laura Radocaj
         (212) 825-3210
         sforman@dgicomm.com
         lradocaj@dgicomm.com